Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 694 of 6351
-
Can a new drug outperform standard care for chemotherapy nerve pain?
Symptom relief CompletedTo conduct a two-arm, parallel, prospective, randomized controlled, open-label trial to compare the efficacy of the novel drug mirogabalin with the conventional treatment duloxetine in reducing pain associated with chemotherapy-induced peripheral neuropathy (CIPN). There will be…
Sponsor: Pusan National University Yangsan Hospital • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
New daily pill could stop painful swelling attacks for HAE patients
Disease control OngoingThis is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of once-daily orally administered deucrictibant extended-release tablet compared to placebo for prophylaxis to prevent angioedema attacks in participants aged ≥ …
Phase 3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Magic mushroom compound shows promise for depression in new trial
Symptom relief CompletedThis randomized controlled clinical trial evaluates the effectiveness of psilocybin and psilocybin-assisted cognitive behavioral therapy (CBT) in the management of Major Depressive Disorder (MDD). The study aims to compare the effects of psilocybin-only therapy, CBT, and psilocyb…
Phase 2 • Sponsor: Khyber Medical University Peshawar • Aim: Symptom relief
Last updated Jun 26, 2026 12:50 UTC
-
New stent aims to save lives from aortic tears
Disease control OngoingStudy Title: "Multi-center Real-world Study on Straight Tubular Thoracic Aortic Perforated Stent-Graft System for Treating Thoracic Aortic Dissection" Purpose: This study aims to evaluate the effectiveness of the Talos stent-graft system, a new device designed to treat aortic …
Sponsor: Qingyou Meng • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
AI-Powered program aims to prevent suicide in native american health systems
Prevention By invitation onlyThe goal of this research is to test a systems-level suicide prevention strategy, Native-RISE (Risk Identification for Suicide and Enhanced care), that combines predictive analytics and brief contact interventions (BCIs) to reduce suicide in health systems serving Native American…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Second chance at breast preservation: new study tests repeat radiation
Disease control Recruiting nowThis study explores whether recurrent breast cancer can be safely treated with breast-conserving surgery and repeated radiation therapy in cases where patients have previously undergone radiation. Traditionally, recurrent breast cancer has been treated by removing the entire brea…
Sponsor: Turku University Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Combination therapy aims to keep leukemia in check after transplant
Disease control Recruiting nowThis prospective study will be conducted in high-risk B-ALL patients post-allo-HSCT. We propose to investigate the safety and therapeutic efficacy of blinatumomab plus low-dose DLI maintenance therapy, with the ultimate goal of enhancing long-term survival outcomes.
Phase 1 • Sponsor: Liping Dou • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can At-Home malaria pills work as well as supervised care?
Disease control CompletedThe study was designed to evaluate the current efficacy of this combination therapy against P. vivax, given the possibility of misuse or inadequate adherence to the regimen due to its lengthy treatment duration, in one of a vivax-endemic area in southwest Ethiopia. A 42-day in vi…
Sponsor: Jimma University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can cord stem cells calm cerebral palsy? a first test in kids
Disease control OngoingThis is a single-center, open-label, single-arm Phase I pilot study designed to evaluate the feasibility and short-term safety of a single intrathecal administration of allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs) in children with cerebral palsy (…
Phase 1 • Sponsor: Gadjah Mada University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New PET tracers could illuminate immune battle inside lung tumors
Diagnosis Recruiting nowThe iRelate is a PET imaging trial to compare two upcoming and promising T cell PET tracers. Following chemo-immuno therapy, as part of standard care, NSCLC patients will be recruited to receive two PET scans, shortly before their surgery. Both PET scans will be compared to each …
Sponsor: Amsterdam UMC, location VUmc • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
Could a steroid injection double as a painkiller for brain surgery?
Symptom relief CompletedThis study aimed to test the hypothesis that pre-emptive scalp infiltration with a steroid (dexamethasone) plus a local anesthetic (xylocaine) could achieve superior postoperative analgesic effects to a local anesthetic (xylocaine) plus epinephrine in adult patients undergoing a …
Sponsor: Assiut University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Zapping the brain without surgery: a new hope for Tough-to-Treat epilepsy
Disease control Recruiting nowThis single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60.
Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
AI takes on HPV vaccine myths: can a chatbot outsmart misinformation?
Prevention CompletedThe goal of this study is to learn if an innovative digital artificial intelligence (AI)-based communication tool works to enhance health literacy among Japanese caregivers regarding Human Papillomavirus (HPV) vaccination. Participants will: * Answer a pre-intervention survey, …
Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
Could a common diabetes drug ease muscle problems in Steinert's disease?
Symptom relief Recruiting nowThe study team hypothesize that non-diabetic patients with Myotonic dystrophy type I (DM1) will improve their symptoms, especially their motor deficit which is the main feature of the disease, because of the splicing defect correction by metformin. The primary objective of the s…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Can a lower dose of an eye drug protect preterm Infants' sight?
Disease control Recruiting nowEvaluating the Optimal Effective Dose and Safety of Conbercept in Treating Retinopathy of Prematurity (ROP)
Sponsor: Wang Yusheng • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New combo therapy aims to stop liver cancer recurrence in High-Risk patients
Disease control Recruiting nowTo assess 1-year recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) who are at high risk of Inguinal orchiectomy recurrence usingTACE combined with icaritin
Phase 2/3 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Gut bacteria test could revolutionize colon cancer screening
Diagnosis Recruiting nowColorectal cancer (CRC) is one of the most common cancer and cause of cancer death worldwide. Population-based screening programs for average-risk populations have proven effective in reducing both incidence and mortality of CRC through early detection of cancer. The fecal immuno…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
New combo therapy shows promise in preventing stroke worsening
Disease control CompletedThis study is an investigator-initiated, multicenter, prospective, open-label, endpoint-blinded, randomized controlled trial (PROBE design) that includes patients with moderate or severe symptomatic intracranial large vessel atherosclerotic stenosis (sICAS) who present with acute…
Phase 2/3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for leukemia patients: asciminib shows promise in indian study
Disease control CompletedThe Drugs Controller General of India (DCGI) has granted approval for Asciminib film-coated 40 mg tablets on 20 Oct 2023 with the condition to perform a Phase IV clinical study in Indian patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can bright light beat insomnia? a new trial investigates
Symptom relief Recruiting nowSleep disorders represent a major public health issue and the leader in these disorders is insomnia with 10 to 15% of subjects in the general population reporting symptoms of insomnia with a daytime impact. In addition to being very common, insomnia leads to an increase in morbid…
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC